Cited by 14Alzheimer's disease research and treatmentsSesquiterpenes and Asteraceae StudiesMedicinal Plants and Neuroprotection

β-amyloid cytotoxicity is prevented by natural achillolide A

Open access
Elmann, Anat, Telerman, Alona, Ofir, Rivka, Kashman, Yoel, Lazarov, Orly·2018·Journal of Natural Medicines

Abstract

Alzheimer's disease (AD) is the most prevalent cause of dementia in adults. Current available drugs for AD transiently alleviate some of the symptoms, but do not modify the disease mechanism or cure it. Therefore, new drugs are desperately needed. Key contributors to AD are amyloid beta (Aβ)- and reactive oxygen species (ROS)-induced cytotoxicities. Plant-derived substances have been shown to affect various potential targets in various diseases including AD. Therefore, phytochemicals which can protect neuronal cells against these insults might help in preventing and treating this disease. In the following research, we have isolated the sesquiterpene lactone achillolide A from the plant Achillea fragrantissima and, for the first time, characterized its effects on Aβ-treated neuroblastoma cells. Aβ is a peptide derived from the sequential cleavage of amyloid precursor protein, and is part of the pathogenesis of AD. Our current study aimed to determine whether achillolide A can interfere with Aβ-induced processes in Neuro2a cells, and protect them from its toxicity. Our results show that achillolide A decreased Aβ-induced death and enhanced the viability of Neuro2a cells. In addition, achillolide A reduced the accumulation of Aβ-induced ROS and inhibited the phosphorylation of stress-activated protein kinase/c-Jun N-terminal kinase and p44/42 mitogen-activated protein kinase in these cells. We therefore suggest that achillolide A may have therapeutic potential for the treatment of AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11418-018-1191-0

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Elmann, A., Telerman, A., Ofir, R., Kashman, Y., & Lazarov, O.
Affiliations
  • Agricultural Research Organization (IL)
  • Dead Sea and Arava Science Center (IL)
  • Tel Aviv University (IL)
  • University of Illinois Chicago (US)
Corresponding author
Elmann, Anat
Venue
Journal of Natural Medicines
Published
2018-03-15
Volume
72
Issue
3
Pages
626-631
ISSN
  • 1340-3443 (ISSN-L)
  • 1861-0293
OpenAlex
W2792542624
Cited by
14
References
38
Citations by year
2026: 2 · 2025: 4 · 2024: 1 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 1
FWCI
0.86
Type
journal article
Language
en
Open access
Locations
  • Journal of Natural Medicines (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
United States - Israel Binational Agricultural Research and Development Fund (IS-4473-11)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Sesquiterpenes and Asteraceae Studies
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
Keywords
amyloid-beta, Alzheimer's disease, sesquiterpene lactones, Achillea fragrantissima, neuroprotection, reactive oxygen species, JNK phosphorylation, MAPK signaling, neuroblastoma cells, cytotoxicity
MeSH terms
Alzheimer Disease, Humans, Plant Extracts, Sesquiterpenes, Amyloid beta-Peptides, Reactive Oxygen Species

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review